ArticleFrontiers in cardiovascular medicine2025
The global burden of hypertension and its epidemiological impacts on adolescents and young adults: projections to 2050.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Patterns of blood pressure and factors associated with hypertension among young adults in Ibadan, Nigeria.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To deeply analyze the epidemiological characteristics of the disease burden of hypertension and its related damages among adolescents and young adults aged 15-39 globally from 1990 to 2021, and predict the trends until 2050, providing key evidence for formulating global public health strategies. Methods: The research data were derived from the Global Burden of Disease (GBD) 2021 database. The epidemiological trends of hypertension were systematically analyzed based on dimensions such as country/region, age, gender, and Socio-demographic Index (SDI). The age-standardization method was used to eliminate the influence of age-structure differences. Multiple statistical methods, including creating global maps, regional comparative analysis, and Joinpoint regression analysis, were employed to explore the distribution and change trends of the disease burden. The Bayesian Age to Period to Cohort (BAPC) model was utilized to predict future trends. Results: From 1990 to 2021, the absolute numbers of hypertension-related deaths, Disability-Adjusted Life Years (DALYs), and Years Lived with Disability (YLDs) increased significantly globally. The age-standardized mortality rate and DALY rate decreased to some extent, while the YLDs rate increased slightly. There were significant differences in the hypertension burden across different regions, countries, SDI regions, genders, and age groups. Predictions indicate that by 2050, the age-standardized mortality rate and DALY rate will generally show a downward trend, while the age-standardized YLDs rate will continue to rise. Conclusion: The burden of hypertension among the global population aged 15-39 is severe and complex, affected by multiple factors. This study provides important reference directions for global public health efforts. In the future, it is necessary to strengthen international cooperation and develop targeted prevention and control strategies to reduce the burden of hypertension-related diseases among adolescents and young adults and promote the healthy development of youth worldwide.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.